MFS
RVMD icon

Mirabella Financial Services’s Revolution Medicines RVMD Stock Holding History

Mirabella Financial Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,282
Closed -$532K – 464
2020
Q3 		$532K Buy
+15,282
New +$423K 0.07% 134

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's RVMD Position: Q4 2020 in Review

Mirabella Financial Services sold out of Revolution Medicines (RVMD) in Q4 2020, closing a stake of 15,282 shares — an estimated $532K sold.

Mirabella Financial Services first reported a position in RVMD in Q3 2020 and held it in 1 quarter. The position peaked at $532K in Q3 2020. 119 funds tracked by Wall St. Rank hold RVMD as of Q4 2020.

  • Mirabella Financial Services reported no remaining Revolution Medicines position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 15,282 Revolution Medicines shares in Q4 2020, an estimated $532K.
  • Mirabella Financial Services first reported a position in Revolution Medicines in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Revolution Medicines position peaked at $532K in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.